(-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1348611 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of NBN mRNA CTD PMID:22079256 (S)-colchicine increases expression EXP 6480464 Colchicine results in increased expression of NBN mRNA CTD PMID:20624997 1,2-dimethylhydrazine affects expression ISO RGD:732723 6480464 1, 2-Dimethylhydrazine affects the expression of NBN mRNA CTD PMID:22206623 17alpha-ethynylestradiol multiple interactions ISO RGD:732723 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of NBN mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:732723 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of NBN mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of NBN mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of NBN mRNA CTD PMID:21215274 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of NBN mRNA CTD PMID:21346803 2-methoxyethanol decreases expression EXP 6480464 methyl cellosolve results in decreased expression of NBN mRNA CTD PMID:19643169 4-hydroxynon-2-enal decreases expression ISO RGD:732723 6480464 4-hydroxy-2-nonenal results in decreased expression of NBN mRNA CTD PMID:19191707 4-hydroxynon-2-enal decreases expression ISO RGD:1348611 6480464 4-hydroxy-2-nonenal results in decreased expression of NBN mRNA CTD PMID:12419474 5-aza-2'-deoxycytidine affects localization ISO RGD:1348611 6480464 Decitabine affects the localization of NBN protein modified form CTD PMID:17991895 5-fluorouracil multiple interactions ISO RGD:1348611 6480464 TP53 protein affects the reaction [Fluorouracil results in decreased expression of NBN mRNA] CTD PMID:15016801 acrolein multiple interactions ISO RGD:1348611 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of NBN mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of NBN mRNA CTD PMID:32699268 aflatoxin M1 decreases expression ISO RGD:1348611 6480464 Aflatoxin M1 results in decreased expression of NBN mRNA CTD PMID:30928695 all-trans-retinoic acid increases expression ISO RGD:1348611 6480464 Tretinoin results in increased expression of NBN mRNA CTD PMID:33167477 alpha-pinene multiple interactions ISO RGD:1348611 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of NBN mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of NBN mRNA CTD PMID:32699268 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of NBN mRNA CTD PMID:16483693 aristolochic acid A multiple interactions EXP 6480464 [aristolochic acid I co-treated with aristolochic acid II] results in decreased expression of NBN mRNA CTD PMID:23912714 aristolochic acid A decreases expression ISO RGD:1348611 6480464 aristolochic acid I results in decreased expression of NBN mRNA CTD PMID:33212167 Aroclor 1254 decreases expression ISO RGD:732723 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of NBN mRNA CTD PMID:23650126 arsenous acid increases expression EXP 6480464 Arsenic Trioxide results in increased expression of NBN protein CTD PMID:23337567 arsenous acid increases expression ISO RGD:1348611 6480464 Arsenic Trioxide results in increased expression of NBN mRNA CTD PMID:17530438 atrazine increases expression ISO RGD:732723 6480464 Atrazine results in increased expression of NBN mRNA CTD PMID:27655631 benzene increases expression ISO RGD:732723 6480464 Benzene results in increased expression of NBN mRNA CTD PMID:15120971 , PMID:15122651 bis(2-chloroethyl) sulfide decreases expression ISO RGD:1348611 6480464 Mustard Gas results in decreased expression of NBN mRNA, Mustard Gas results in decreased expression of NBN protein CTD PMID:12884408 , PMID:29217481 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of NBN mRNA CTD PMID:25181051 bisphenol A decreases expression ISO RGD:732723 6480464 bisphenol A results in decreased expression of NBN mRNA CTD PMID:33221593 butanal decreases expression ISO RGD:1348611 6480464 butyraldehyde results in decreased expression of NBN mRNA CTD PMID:26079696 caffeine affects phosphorylation ISO RGD:1348611 6480464 Caffeine affects the phosphorylation of NBN protein CTD PMID:35688186 celastrol decreases expression ISO RGD:1348611 6480464 celastrol results in decreased expression of NBN mRNA CTD PMID:17010675 CGP 52608 multiple interactions ISO RGD:1348611 6480464 CGP 52608 promotes the reaction [RORA protein binds to NBN gene] CTD PMID:28238834 cisplatin increases phosphorylation ISO RGD:732723 6480464 Cisplatin results in increased phosphorylation of NBN protein CTD PMID:22006019 cisplatin multiple interactions ISO RGD:1348611 6480464 [Cisplatin results in decreased susceptibility to Cisplatin] which results in increased expression of NBN mRNA CTD PMID:30871063 cisplatin increases expression ISO RGD:1348611 6480464 Cisplatin results in increased expression of NBN protein CTD PMID:26723870 cisplatin increases expression ISO RGD:732723 6480464 Cisplatin results in increased expression of NBN protein CTD PMID:26723870 cisplatin multiple interactions ISO RGD:732723 6480464 NQO1 protein affects the reaction [Cisplatin results in increased expression of NBN protein] CTD PMID:26723870 copper(II) sulfate increases expression ISO RGD:1348611 6480464 Copper Sulfate results in increased expression of NBN mRNA CTD PMID:19549813 delphinidin increases expression ISO RGD:1348611 6480464 delphinidin results in increased expression of NBN mRNA CTD PMID:19182879 diarsenic trioxide increases expression EXP 6480464 Arsenic Trioxide results in increased expression of NBN protein CTD PMID:23337567 diarsenic trioxide increases expression ISO RGD:1348611 6480464 Arsenic Trioxide results in increased expression of NBN mRNA CTD PMID:17530438 dorsomorphin multiple interactions ISO RGD:1348611 6480464 [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NBN mRNA CTD PMID:27188386 doxorubicin multiple interactions ISO RGD:1348611 6480464 Acetylcysteine inhibits the reaction [Doxorubicin promotes the reaction [ATM protein results in increased phosphorylation of NBN protein]], Doxorubicin promotes the reaction [ATM protein results in increased phosphorylation of NBN protein] CTD PMID:15489221 doxorubicin decreases expression ISO RGD:1348611 6480464 Doxorubicin results in decreased expression of NBN mRNA CTD PMID:29803840 doxorubicin multiple interactions EXP 6480464 Fungal Polysaccharides inhibits the reaction [Doxorubicin results in increased expression of NBN mRNA] CTD PMID:27181935 doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of NBN mRNA CTD PMID:27181935 entinostat decreases expression ISO RGD:1348611 6480464 entinostat results in decreased expression of NBN mRNA CTD PMID:27188386 enzyme inhibitor multiple interactions ISO RGD:1348611 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of NBN protein CTD PMID:23301498 fenofibrate multiple interactions EXP 6480464 [Fenofibrate co-treated with Diethylnitrosamine] results in increased expression of NBN mRNA CTD PMID:18253720 , PMID:18775883 fenofibrate increases expression EXP 6480464 Fenofibrate results in increased expression of NBN mRNA CTD PMID:17264098 , PMID:18775883 finasteride increases expression EXP 6480464 Finasteride results in increased expression of NBN mRNA CTD PMID:24136188 folic acid decreases expression ISO RGD:732723 6480464 Folic Acid results in decreased expression of NBN mRNA CTD PMID:25629700 gedunin decreases expression ISO RGD:1348611 6480464 gedunin results in decreased expression of NBN mRNA CTD PMID:17010675 genistein multiple interactions ISO RGD:1348611 6480464 ESR1 promotes the reaction [Genistein results in increased expression of NBN protein] CTD PMID:20884965 genistein increases expression ISO RGD:1348611 6480464 Genistein results in increased expression of NBN protein CTD PMID:20884965 glafenine decreases expression EXP 6480464 Glafenine results in decreased expression of NBN mRNA CTD PMID:24136188 hexadecanoic acid decreases phosphorylation ISO RGD:1348611 6480464 Palmitic Acid results in decreased phosphorylation of NBN protein CTD PMID:28073184 isoprenaline decreases expression ISO RGD:732723 6480464 Isoproterenol results in decreased expression of NBN mRNA CTD PMID:21335049 isoprenaline increases expression ISO RGD:732723 6480464 Isoproterenol results in increased expression of NBN mRNA CTD PMID:21335049 isotretinoin decreases expression ISO RGD:1348611 6480464 Isotretinoin results in decreased expression of NBN mRNA CTD PMID:20436886 ivermectin decreases expression ISO RGD:1348611 6480464 Ivermectin results in decreased expression of NBN protein CTD PMID:32959892 methylmercury chloride increases expression ISO RGD:1348611 6480464 methylmercuric chloride results in increased expression of NBN mRNA CTD PMID:23179753 , PMID:26272509 methylmercury chloride multiple interactions ISO RGD:1348611 6480464 [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NBN mRNA CTD PMID:27188386 myristicin decreases expression ISO RGD:1348611 6480464 myristicin results in decreased expression of NBN mRNA CTD PMID:24792648 N-acetyl-L-cysteine multiple interactions ISO RGD:1348611 6480464 Acetylcysteine inhibits the reaction [Doxorubicin promotes the reaction [ATM protein results in increased phosphorylation of NBN protein]] CTD PMID:15489221 N-methyl-4-phenylpyridinium decreases expression ISO RGD:1348611 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of NBN mRNA CTD PMID:24810058 N-nitrosodiethylamine multiple interactions EXP 6480464 [Fenofibrate co-treated with Diethylnitrosamine] results in increased expression of NBN mRNA CTD PMID:18253720 , PMID:18775883 Nonidet P-40 increases expression ISO RGD:1348611 6480464 Nonidet P-40 results in increased expression of NBN mRNA CTD PMID:26552463 oxaliplatin decreases expression EXP 6480464 oxaliplatin results in decreased expression of NBN mRNA CTD PMID:25729387 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of NBN mRNA CTD PMID:25729387 ozone multiple interactions ISO RGD:1348611 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of NBN mRNA more ... CTD PMID:32699268 paracetamol affects expression ISO RGD:732723 6480464 Acetaminophen affects the expression of NBN mRNA CTD PMID:17562736 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of NBN mRNA CTD PMID:33387578 paracetamol decreases expression ISO RGD:1348611 6480464 Acetaminophen results in decreased expression of NBN mRNA CTD PMID:21420995 paraquat multiple interactions ISO RGD:732723 6480464 [ATG7 protein affects the susceptibility to Paraquat] which affects the expression of NBN mRNA CTD PMID:28012437 parathion increases expression ISO RGD:732723 6480464 Parathion results in increased expression of NBN mRNA CTD PMID:34813904 pentamidine affects localization ISO RGD:1348611 6480464 Pentamidine affects the localization of NBN protein CTD PMID:20144237 pirinixic acid multiple interactions ISO RGD:732723 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of NBN mRNA, PPARA protein promotes the reaction [pirinixic acid results in increased expression of NBN mRNA] CTD PMID:17950772 , PMID:19710929 pirinixic acid increases expression ISO RGD:732723 6480464 pirinixic acid results in increased expression of NBN mRNA CTD PMID:17950772 more ... pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of NBN mRNA CTD PMID:22484513 potassium chromate decreases expression ISO RGD:1348611 6480464 potassium chromate(VI) results in decreased expression of NBN mRNA CTD PMID:22079256 potassium chromate multiple interactions ISO RGD:1348611 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of NBN mRNA CTD PMID:22079256 potassium dichromate increases expression ISO RGD:1348611 6480464 Potassium Dichromate results in increased expression of NBN protein CTD PMID:23718831 Ptaquiloside decreases expression ISO RGD:1348611 6480464 ptaquiloside results in decreased expression of NBN mRNA CTD PMID:22143989 quercetin decreases expression ISO RGD:1348611 6480464 Quercetin results in decreased expression of NBN mRNA CTD PMID:21632981 resveratrol decreases expression ISO RGD:1348611 6480464 resveratrol results in decreased expression of NBN protein CTD PMID:22644231 resveratrol increases phosphorylation ISO RGD:1348611 6480464 resveratrol results in increased phosphorylation of NBN protein CTD PMID:24933654 resveratrol decreases expression ISO RGD:732723 6480464 resveratrol results in decreased expression of NBN protein CTD PMID:25505154 resveratrol multiple interactions ISO RGD:1348611 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of NBN mRNA, Resveratrol results in decreased expression of [MRE11 protein binds to NBN protein binds to RAD50 protein] CTD PMID:22644231 , PMID:23557933 riddelliine multiple interactions ISO RGD:1348611 6480464 [CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of NBN mRNA CTD PMID:33884520 SB 431542 multiple interactions ISO RGD:1348611 6480464 [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NBN mRNA CTD PMID:27188386 topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of NBN mRNA CTD PMID:25729387 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of NBN mRNA CTD PMID:25729387 trichostatin A affects expression ISO RGD:1348611 6480464 trichostatin A affects the expression of NBN mRNA CTD PMID:28542535 triptonide decreases expression ISO RGD:732723 6480464 triptonide results in decreased expression of NBN mRNA CTD PMID:33045310 valproic acid decreases methylation ISO RGD:1348611 6480464 Valproic Acid results in decreased methylation of NBN gene CTD PMID:29154799 valproic acid decreases expression ISO RGD:1348611 6480464 Valproic Acid results in decreased expression of NBN mRNA CTD PMID:23179753 , PMID:27188386 valproic acid affects expression ISO RGD:1348611 6480464 Valproic Acid affects the expression of NBN mRNA CTD PMID:25979313 valproic acid affects expression ISO RGD:732723 6480464 Valproic Acid affects the expression of NBN mRNA CTD PMID:17963808 valproic acid decreases expression ISO RGD:732723 6480464 Valproic Acid results in decreased expression of NBN mRNA CTD PMID:21427059 vincaleukoblastine increases expression EXP 6480464 Vinblastine results in increased expression of NBN mRNA CTD PMID:20624997 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of NBN mRNA CTD PMID:23034163 vincristine increases expression EXP 6480464 Vincristine results in increased expression of NBN mRNA CTD PMID:20624997 vorinostat decreases expression ISO RGD:1348611 6480464 vorinostat results in decreased expression of NBN mRNA CTD PMID:27188386